Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 5, 2010, Pages 1445-1450

  Paulino, Arnold C ^a,b,c   Lobo, Mark ^c   Teh, Bin S ^a,c   Okcu, M Fatih ^b,c   South, Michael ^a   Butler, E Brian ^a   Su, Jack ^b,c   Chintagumpala, Murali ^b,c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Children; Cochlea; Medulloblastoma; Ototoxicity; Radiation dose

Indexed keywords

CHILDREN; COCHLEA; MEDULLOBLASTOMA; OTOTOXICITY; RADIATION DOSE;

AUDITION; CHEMOTHERAPY; DOSIMETRY; PATIENT MONITORING; PLATINUM COMPOUNDS; RADIATION; RADIOTHERAPY;

PHYSICAL THERAPY;

AMIFOSTINE; CISPLATIN;

ARTICLE; AUDIOGRAPHY; AUDITORY THRESHOLD; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILD; CLINICAL ARTICLE; COCHLEA; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HEARING AID; HEARING LOSS; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; OTOTOXICITY; POSTERIOR FOSSA; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; RADIATION DOSE; RADIATION INJURY; SCHOOL CHILD;

ADOLESCENT; AMIFOSTINE; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; COCHLEA; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HEARING LOSS; HUMANS; MALE; MEDULLOBLASTOMA; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 78549273985     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.031     Document Type: Article

References (23)

1. A. Gajjar, M. Chintagumpala, and D. Ashley Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St. Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial Lancet Oncol 7 2006 813 820
2. T.E. Merchant, L.E. Kun, and M.J. Krasin Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma Int J Radiat Oncol Biol Phys 70 2008 782 787
3. A.C. Paulino, A. Narayana, and M.N. Mohideen Posterior fossa boost in medulloblastoma: An analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy Int J Radiat Oncol Biol Phys 46 2000 281 286
4. E. Huang, B.S. Teh, and D.R. Strother Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity Int J Radiat Oncol Biol Phys 55 2003 599 605
5. N.J. Tarbell, A.R. Smith, and J. Adams The challenge of conformal radiotherapy in the curative treatment of medulloblastoma Int J Radiat Oncol Biol Phys 46 2000 265 266
6. M. South, J.K. Chiu, and B.S. Teh Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: Early experience at Methodist Hospital Int J Radiat Oncol Biol Phys 71 2008 477 483
7. R.J. Packer, A. Gajjar, and G. Vezina Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma J Clin Oncol 24 2006 4202 4208
8. M. Fouladi, M. Chintagumpala, and D. Ashley Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma J Clin Oncol 26 2008 3749 3755
9. A.C. Paulino, C.B. Saw, and B.C. Wen Comparison of posterior fossa and tumor bed boost in medulloblastoma Am J Clin Oncol 23 2000 487 490
10. P. Bertolini, M. Lassalle, and G. Mercier Platinum compound-related ototoxicity in children: Long-term follow-up reveals continuous worsening of hearing loss J Pediatr Hematol Oncol 26 2004 649 655
11. C. Hua, J.K. Bass, and R. Khan Hearing loss after radiotherapy for pediatric brain tumors: Effect of cochlear dose Int J Radiat Oncol Biol Phys 72 2008 892 899
12. W.R. Polkinghom, I.J. Dunkel, and M.M. Souweidane Outcomes using IMRT tumor-bed boost for medulloblastoma Int J Radiat Oncol Biol Phys 72S 2008 S79 S80
13. D.L. Kwong, W.I. Wei, and J.S. Sham Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment Int J Radiat Oncol Biol Phys 36 1996 281 289
14. W.C. Chen, A. Jackson, and A.S. Budnick Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma Cancer 106 2006 820 829
15. Y.T. Oh, C.H. Kim, and J.H. Choi Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma Radiother Oncol 72 2004 79 82
16. S.H. Chan, W.T. Ng, and K.L. Kam Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: A longitudinal analysis Int J Radiat Oncol Biol Phys 73 2009 1335 1342
17. C.L. Zuur, Y.J. Simis, and P.E. Lansdaal Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: A multivariate analysis Int J Radiat Oncol Biol Phys 68 2007 1320 1325
18. Y.J. Hitchcock, J.D. Tward, and A. Szabo Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients Int J Radiat Oncol Biol Phys 73 2009 779 788
19. M.J. Fisher, B.J. Lange, and M.N. Needle Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy Pediatr Blood Cancer 43 2004 780 784
20. Soomal R, Saran F, Brada M. In regard to Huang, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. IJROBP 2002;52:599-605. Int J Radiat Oncol Biol Phys 2003;55:853.
21. N. Jain, K.R. Krull, and P. Brouwers Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma Pediatr Blood Cancer 51 2008 275 279
22. E.J. Hall Intensity-modulated radiation therapy, protons, and the risk of second cancers Int J Radiat Oncol Biol Phys 65 2006 1 7
23. R. Miralbell, A. Lomax, and L. Cella Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors Int J Radiat Oncol Biol Phys 54 2002 824 829